Argenx
ARGX
#476
Rank
โ‚น4.851 T
Marketcap
โ‚น77,637
Share price
-1.72%
Change (1 day)
53.04%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น825.26. In 2024 the company made an earnings per share (EPS) of โ‚น1,295 an increase over its 2023 EPS that were of -โ‚น480.09.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-40.03%
2024โ‚น1,295-369.77%
2023-โ‚น480.09-60.46%
2022-โ‚น1,21463.33%
2021-โ‚น743.39-40.37%
2020-โ‚น1,247183.47%
2019-โ‚น439.81123.09%
2018-โ‚น197.1554.93%
2017-โ‚น127.2514.07%
2016-โ‚น111.5513.05%
2015-โ‚น98.67-36.34%
2014-โ‚น155.00209.04%
2013-โ‚น50.15-33.99%
2012-โ‚น75.98185.59%
2011-โ‚น26.61